Development of 3,4-dihydro-2H-benzo[1,4]oxazine derivatives as dual thromboxane A2 receptor antagonists and prostacyclin receptor agonists - Ohno, M; Tanaka, Y; Miyamoto, M (Bioorg Med Chem, 2006)